...
首页> 外文期刊>Nature medicine >CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
【24h】

CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants

机译:因果丝:用于建立非编码GWAS变体功能的外延簇和基因组编辑管道

获取原文
获取原文并翻译 | 示例

摘要

The vast majority of disease-associated single-nucleotide polymorphisms (SNPs) mapped by genome-wide association studies (GWASs) are located in the non-protein-coding genome, but establishing the functional and mechanistic roles of these sequence variants has proven challenging. Here we describe a general pipeline in which candidate functional SNPs are first evaluated by fine mapping, epigenomic profiling, and epigenome editing, and then interrogated for causal function by using genome editing to create isogenic cell lines followed by phenotypic characterization. To validate this approach, we analyzed the 6q22.1 prostate cancer risk locus and identified rs339331 as the top-scoring SNP. Epigenome editing confirmed that the rs339331 region possessed regulatory potential. By using transcription activator-like effector nuclease (TALEN)-mediated genome editing, we created a panel of isogenic 22Rv1 prostate cancer cell lines representing all three genotypes (TT, TC, CC) at rs339331. Introduction of the 'T' risk allele increased transcription of the regulatory factor 6 (RFX6) gene, increased homeobox B13 (HOXB13) binding at the rs339331 region, and increased deposition of the enhancer-associated H3K4me2 histone mark at the rs339331 region compared to lines homozygous for the 'C' protective allele. The cell lines also differed in cellular morphology and adhesion, and pathway analysis of differentially expressed genes suggested an influence of androgens. In summary, we have developed and validated a widely accessible approach that can be used to establish functional causality for noncoding sequence variants identified by GWASs.
机译:通过基因组 - 宽协会研究(Gwass)映射的绝大多数疾病相关的单核苷酸多态性(SNP)位于非蛋白质编码基因组中,但建立了这些序列变体的功能和机械作用已被证明是具有挑战性的。在这里,我们描述了一种通过精细的映射,表观蛋白分析和外形组织编辑来评估候选功能SNP的一般管线,然后通过使用基因组编辑来询问因果函数,以产生同种型细胞系,然后进行表型表征。为了验证这种方法,我们分析了6Q22.1前列腺癌风险基因座,并确定了RS339331作为彩色得分SNP。表观群体编辑证实,RS339331区域具有调节潜力。通过使用转录活化剂样效应核素核酸酶(TALEN)介导的基因组编辑,我们在RS33931中创建了代表所有三种基因型(TT,TC,CC)的中源性22RV1前列腺癌细胞系。引入“T”风险等位基因增加了调节因子6(RFX6)基因的转录,在RS339331区域增加了Homeobox B13(Hoxb13)结合,并与线相比,在RS339331区域的增强子相关H3K4ME2组蛋白标记增加纯合'C'保护等位基因。细胞系也不同于细胞形态和粘附性,并且差异表达基因的途径分析表明Androgens的影响。总之,我们已经开发并验证了广泛可接近的方法,可用于建立由Gwass识别的非编码序列变体的功能因果关系。

著录项

  • 来源
    《Nature medicine 》 |2015年第11期| 共7页
  • 作者单位

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Univ So Calif Keck Sch Med Dept Prevent Med Los Angeles CA 90033 USA;

    Massachusetts Gen Hosp Mol Pathol Unit Charlestown MA USA;

    Eotvos Lorand Univ Dept Phys Complex Syst Budapest Hungary;

    Massachusetts Gen Hosp Mol Pathol Unit Charlestown MA USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Univ So Calif Keck Sch Med Dept Prevent Med Los Angeles CA 90033 USA;

    Univ So Calif Keck Sch Med Dept Prevent Med Los Angeles CA 90033 USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Boston Childrens Hosp CHIP Boston MA USA;

    Dana Farber Canc Inst Mol Biol Core Facil Boston MA 02115 USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

    Szent Istvan Univ Dept Anim Hyg Budapest Hungary;

    Univ So Calif Keck Sch Med Dept Prevent Med Los Angeles CA 90033 USA;

    Massachusetts Gen Hosp Mol Pathol Unit Charlestown MA USA;

    Dana Farber Canc Inst Dept Med Oncol Boston MA 02115 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号